Replies to post #8241 on Inergetics Inc (fka NRTI)

[brookswashere]

Gross margin of 24% with overhead of $3MM per quarter means this company needs revenue of $50+MM per annum to break-even. Doesn't seem likely in the foreseeable future.

The Company burned through all of the EDA money on overhead (no capital investment, pay-down of debt, cash reserves, etc).

Maybe Mr. James was more focused on his CFO duties for TRTC, although they lost $4.9MM during 1Q 2014 as well which means Mr. James' had almost $10MM in losses in a three month period between the two companies.

[crookedneck]

I must admit you are correct. I did expect them to recognize the initial shipment to Walgreen's in this 1st qtr based on what was stated in their 2013 3rd qtr earnings, but as we see this is not the case now. Obviously the terms were much different than what I thought and probably the reason the actual terms were not disclosed. I take full responsibility for my error here and will no longer make these assumptions in the future. I will remain a long term shareholder here, but keep my projections in check. I will however, try to connect with Mr. James to gain a full understanding of how this revenue from Walgreen's will be recognized and when.

I do agree that NRTI is still in the early stages of this turn around and has a very viable plan in place to become a profitable business down the road. I expect the announcement of their new CBD products to be the upcoming catalyst to revitalize the share price to new heights. After reading through the 1st qtr earnings, I took notice of the 7,000% increase in sales vs prev yr 1st qtr. It is clear that sales and revenue continue to grow each and every quarter since new management stepped in.

I still believe the share price will surpass the $1.00 mark by the end of the year due to the entry into the CBD category with the new TRTC partnership. It was duly noted by liodog about the difference in the share price comparison between NRTI & TRTC, whereas NRTI had greater revenue than TRTC, but a much lower share price, thus making NRTI a better investment for the CBD product roll out. From this point on I shall watch and monitor the situation, without voicing a prediction or expectation, which I have been wrong about the last few times, in which I apologize for.

I believe the future is still very bright and that all us long term investors will be greatly rewarded this year and future years as new management implements their growth plan. I also expect future acquisitions that will continue to increase revenues for the company.

Cheers!